Carl Olsson, MD, compared the efficacy of LHRH agonists with antagonists, which are commonly used to treat patients with prostate cancer. Tune in here.
Carl Olsson, MD, compared the efficacy of LHRH agonists with antagonists, which are commonly used to treat patients with prostate cancer. Tune in here.